Also trades as: OCEAW (NASDAQ) · $vol 0M
OCEA OTC
Ocean Biomedical, Inc.
1W: +6.2%
1M: -15.0%
3M: +183.3%
YTD: -46.9%
1Y: -83.0%
3Y: -100.0%
$0.00
+0.00 (+6.25%)
Weekly Expected Move ±454.9%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
$0
+0.0% ▲
Net Income
-$3M
+0.0% ▲
EPS (Diluted)
$-0.12
+0.0% ▲
EBITDA
$0
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $35K | $49K | $34M | $0 | $26K |
| SG&A Expenses | $197K | $2M | $28M | $2M | $4M |
| Operating Expenses | $232K | $2M | $567K | $2M | $4M |
| Operating Income | -$232K | -$2M | -$567K | -$2M | $0 |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $691 | -$2M |
| Income Before Tax | -$232K | -$2M | -$564K | -$958K | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$232K | -$2M | -$62M | $565K | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.08 | $-0.04 | $-0.05 | $-0.12 |
| EBITDA | -$232K | -$2M | -$328K | -$958K | $0 |
| Shares Outstanding | 20M | 20M | 13M | 19M | 28M |